08 Apr 2005
| by Ian Hall
said.
The Committee said some GPs were too easily swayed by firms' PR tactics and fail to properly ...
11 Feb 2005
professionals ourselves, we have our own views too,' he adds.
Instant access
Hawkes sees some benefits ...
an ideal world, you would get someone else to quote too, but not all experts are aware of all ...
upon healthcare PR - you have to get at people in another way.
'Sometimes there is too much weight ...
28 Jan 2005
| by Dan Bloch
that for some time to come.
RESUME
1996: Marketing and PR assistant, Grant Thornton
1997: Press office ...
14 Jan 2005
| by Kate Nicholas, kate.nicholas@haynet.com
.
The obvious lack of understanding of advertising and PR led to some moments of borderline farce ...
07 Jan 2005
will not become concrete for many months, if not years.
Some of those PROs present at the hearing were clearly ...
, it seemed to others that some MPs were unable to draw a distinction between different marketing disciplines ...
03 Dec 2004
of drugs firms. Chairman Steve Kerridge says: 'Some GPs only have one or two three-minute slots a year when they will see reps, and appointments have to be made a year in advance.
Gaining access to GPs is not getting ...
supporting the rep in the battle to get a foot in the door: 'Reps can empower practice managers to solve ...
03 Dec 2004
favourable reviews of drugs into some of the most respected peer-review medical journals, including The Lancet and the British Medical Journal (BMJ).
In some cases, doctors and experts in various medical ...
, are well placed - but that this is not enough to get the message through.
Nowhere to hide
'The pharma ...
01 Oct 2004
| by Ian Hall
to the pharma industry by her husband, getting work as a sales rep for Lederle Laboratories - now ...
then - and which continues to do so - is Interaction Marketing and PR, whose MD Karen Rowe says: 'Some PR people ...
06 Aug 2004
used to get a better understanding of the brand,' says Red Door Communications managing director ...
some of the learnings from consumer branding into ethical healthcare for at least a year.'
A case ...
the pharma industry suffers from something of a perception problem, it may not be as severe as some might ...
02 Jul 2004
strategy'
Given the media mauling engendered by the Seroxat controversy, some have viewed GSK's decision ...